# FDA Inspection 1203851 - Deretil, S.A. - March 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/deretil-sa/08600e27-fed5-4bd5-a87c-4af60fbb922b
Source feed: FDA_Inspections

> FDA Inspection 1203851 for Deretil, S.A. on March 24, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203851
- Company Name: Deretil, S.A.
- Inspection Date: 2023-03-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1132248 - 2019-03-13](https://www.keypedia.com/records/fda_inspections/deretil-sa/a4aaf0dd-7424-4b05-b3e2-35668f269000)
- [FDA Inspection 956681 - 2016-01-08](https://www.keypedia.com/records/fda_inspections/deretil-sa/c5e2610e-e90c-4a17-8fe7-3c9a5e913395)
- [FDA Inspection 850522 - 2013-09-26](https://www.keypedia.com/records/fda_inspections/deretil-sa/7460e268-eebc-4a3e-9458-b7703f34e93f)
- [FDA Inspection 674453 - 2010-07-01](https://www.keypedia.com/records/fda_inspections/deretil-sa/9beee819-b730-4e84-9245-378c7f1f0886)

Company: https://www.keypedia.com/companies/deretil-sa/39f0d91d-3c36-4439-b6e9-c663ab3bfe7d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c